Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin. 1975

H B Kostenbauder, and R P Rapp, and J P McGovren, and T S Foster, and D G Perrier, and H M Blacker, and W C Hulon, and A W Kinkel

Comparison of phenytoin plasma concentrations in an intravenous and intramuscular crossover study in 12 healthy ambulant, male subjects indicates that phenytoin administered intramuscularly is absorbed over a period of approximately five days. A model simulating precipitation and redissolution of the drug at the injection site has been shown to satisfactorily fit observed plasma concentration data following intramuscular administration. It is proposed that this model will be useful in the selection of an appropriate dosing regimen in situations in which intramuscular administration of phenytoin is indicated.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H B Kostenbauder, and R P Rapp, and J P McGovren, and T S Foster, and D G Perrier, and H M Blacker, and W C Hulon, and A W Kinkel
February 1976, Clinical pharmacology and therapeutics,
H B Kostenbauder, and R P Rapp, and J P McGovren, and T S Foster, and D G Perrier, and H M Blacker, and W C Hulon, and A W Kinkel
September 2020, Journal of veterinary pharmacology and therapeutics,
H B Kostenbauder, and R P Rapp, and J P McGovren, and T S Foster, and D G Perrier, and H M Blacker, and W C Hulon, and A W Kinkel
March 1983, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
H B Kostenbauder, and R P Rapp, and J P McGovren, and T S Foster, and D G Perrier, and H M Blacker, and W C Hulon, and A W Kinkel
September 2010, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians,
H B Kostenbauder, and R P Rapp, and J P McGovren, and T S Foster, and D G Perrier, and H M Blacker, and W C Hulon, and A W Kinkel
January 1984, European journal of clinical pharmacology,
H B Kostenbauder, and R P Rapp, and J P McGovren, and T S Foster, and D G Perrier, and H M Blacker, and W C Hulon, and A W Kinkel
March 1997, Journal of the neurological sciences,
H B Kostenbauder, and R P Rapp, and J P McGovren, and T S Foster, and D G Perrier, and H M Blacker, and W C Hulon, and A W Kinkel
January 1994, Biopharmaceutics & drug disposition,
H B Kostenbauder, and R P Rapp, and J P McGovren, and T S Foster, and D G Perrier, and H M Blacker, and W C Hulon, and A W Kinkel
August 1982, British journal of clinical pharmacology,
H B Kostenbauder, and R P Rapp, and J P McGovren, and T S Foster, and D G Perrier, and H M Blacker, and W C Hulon, and A W Kinkel
September 2014, Pharmacotherapy,
H B Kostenbauder, and R P Rapp, and J P McGovren, and T S Foster, and D G Perrier, and H M Blacker, and W C Hulon, and A W Kinkel
June 1992, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!